Related Experiment Video
Updated: Jun 16, 2026

Using Microtiter Dish Radiolabeling for Multiple In Vivo Measurements Of Escherichia coli (p)ppGpp Followed by Thin Layer Chromatography
Published on: June 4, 2019
[PPARgamma target genes and the molecular mechanism of transcriptional control by PPARgamma]
Makoto Nishizuka1, Masayoshi Imagawa
1Department of Molecular Biology, Graduate School of Pharmaceutical Sciences, Nagoya City University.
Abstract:
Peroxisome proliferator-activated receptor gamma (PPARgamma) agonist such as thiazolidinedione (TZD) has important roles in inflammation and cancer in addition to the control of energy conservation, adipocyte differentiation and insulin sensitivity. PPARgamma is a ligand-activated nuclear receptor. In the absence of ligand, the transcriptional activity of PPARgamma is suppressed through the association with N-CoR/SMRT and histone deacetylases. Upon binding of ligand to PPARgamma, PPARgamma binds several coactivators and regulates the expression of its target genes in various tissues. To understand various effects of TZD, we summarize the transcriptional control by PPARgamma focused on coactivators and target genes regulated by PPARgamma.
Insights
Peroxisome proliferator-activated receptor gamma (PPARgamma) agonists, like thiazolidinediones (TZDs), regulate energy, insulin sensitivity, and inflammation. This review details how PPARgamma coactivators and target genes control these vital cellular processes.
Area of Science:
- Molecular biology
- Endocrinology
- Cell biology
Context:
- Peroxisome proliferator-activated receptor gamma (PPARgamma) is a nuclear receptor crucial for metabolic regulation.
- PPARgamma activity is modulated by ligand binding, influencing gene expression.
- Thiazolidinediones (TZDs) are known PPARgamma agonists with diverse physiological effects.
Purpose:
- To elucidate the transcriptional regulation mechanisms of PPARgamma.
- To focus on the role of coactivators and target genes in PPARgamma's function.
- To provide a comprehensive overview of TZD-mediated effects through PPARgamma.
Summary:
- PPARgamma, a ligand-activated nuclear receptor, controls energy conservation, adipocyte differentiation, and insulin sensitivity.
- In its inactive state, PPARgamma's transcription is repressed by corepressors like N-CoR/SMRT and histone deacetylases.
- Ligand binding activates PPARgamma, leading to coactivator recruitment and regulation of target gene expression in various tissues.
Impact:
- Understanding PPARgamma transcriptional control is key to developing targeted therapies for metabolic and inflammatory diseases.
- This review highlights the critical role of coactivators and target genes in mediating the pleiotropic effects of PPARgamma agonists.
- Insights into PPARgamma regulation can inform strategies for managing conditions like diabetes, inflammation, and cancer.
Related Concept Videos
RNA Polymerase II Accessory Proteins
Master Transcription Regulators
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Co-activators and Co-repressors
Co-activators and Co-repressors

